Galapagos NV
GLPG
#4525
Rank
โ‚น201.16 B
Marketcap
โ‚น3,053
Share price
0.45%
Change (1 day)
35.29%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: โ‚น201.16 Billion

As of March 2026 Galapagos NV has a market cap of โ‚น201.16 Billion. This makes Galapagos NV the world's 4525th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น201.16 B2.95%
2025โ‚น195.39 B26.61%
2024โ‚น154.32 B-30.79%
2023โ‚น223.00 B-7.77%
2022โ‚น241.77 B-11.08%
2021โ‚น271.90 B-42.58%
2020โ‚น473.53 B-50.85%
2019โ‚น963.38 B174.51%
2018โ‚น350.95 B14.45%
2017โ‚น306.65 B51.43%
2016โ‚น202.50 B23.62%
2015โ‚น163.81 B352.89%
2014โ‚น36.17 B-6.59%
2013โ‚น38.72 B25.14%
2012โ‚น30.94 B63.99%
2011โ‚น18.86 B-1.02%
2010โ‚น19.06 B61.18%
2009โ‚น11.82 B139.45%
2008โ‚น4.93 B

End of Day market cap according to different sources

On Mar 10th, 2026 the market cap of Galapagos NV was reported to be:

โ‚น201.16 Billion
by Nasdaq info icon info icon
โ‚น201.16 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น53.986 T 26,737.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น17.657 T 8,677.98%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น36.895 T 18,241.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น9.761 T 4,752.36%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น26.610 T 13,128.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น27.786 T 13,713.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น10.185 T 4,963.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
โ‚น9.58 B-95.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น3.374 T 1,577.42%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel